Gluten & Me

Downloads
Revenue

Description

Gluten kasalligi, baʼzida glyutenga sezgir enteropatiya deb ataladi, bug'doy, arpa va javdarda mavjud bo'lgan protein bo'lgan kleykovina yeyishga qarshi immunitet reaktsiyasidir.
Agar sizda kolyak kasalligi bo'lsa, kleykovina iste'mol qilish ingichka ichakda immunitet reaktsiyasini keltirib chiqaradi. Vaqt o'tishi bilan bu reaktsiya ingichka ichakning shilliq qavatiga zarar etkazadi va u ba'zi oziq moddalarni o'zlashtirishiga to'sqinlik qiladi (malabsorbtsiya). Ichakning shikastlanishi ko'pincha diareya, charchoq, vazn yo'qotish, shish va anemiyaga olib keladi va jiddiy asoratlarga olib kelishi mumkin.
Bolalarda malabsorbtsiya o'sish va rivojlanishga ta'sir qilishi mumkin, bundan tashqari, kattalardagi alomatlar ham paydo bo'lishi mumkin.
Kolyak kasalligini davolab bo'lmaydi — lekin ko'pchilik uchun glyutensiz qat'iy dietaga rioya qilish simptomlarni boshqarishga va ichakni davolashga yordam beradi.
Hide Show More...

Screenshots

Gluten & Me FAQ

  • Is Gluten & Me free?

    Yes, Gluten & Me is completely free and it doesn't have any in-app purchases or subscriptions.

  • Is Gluten & Me legit?

    Not enough reviews to make a reliable assessment. The app needs more user feedback.

    Thanks for the vote

  • How much does Gluten & Me cost?

    Gluten & Me is free.

  • What is Gluten & Me revenue?

    To get estimated revenue of Gluten & Me app and other AppStore insights you can sign up to AppTail Mobile Analytics Platform.

User Rating
App is not rated in Australia yet.
Ratings History

Gluten & Me Reviews

No Reviews in Australia
App doesn't have any reviews in Australia yet.

Store Rankings

Ranking History
App Ranking History not available yet
Category Rankings
App is not ranked yet

Gluten & Me Installs

Last 30 days

Gluten & Me Revenue

Last 30 days

Gluten & Me Revenue and Downloads

Gain valuable insights into Gluten & Me performance with our analytics.
Sign up now to access downloads, revenue, and more.

App Info

Languages
English
Recent release
1.0.7 (5 months ago )
Released on
Jun 12, 2024 (6 months ago )
Last Updated
1 week ago
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.